Home›Companies›Healthcare›Biomakers

Biomakers, Inc.

Biomakers provides cancer testing and data services to patients, physicians and life sciences companies.

Updated Nov 10, 2026·Latest SEC filing Apr 29, 2026·Suggest an edit

About Biomakers

Biomakers is a private company based in City of Dover, County of Kent, Delaware. It has reported $5,901,147 raised in one offering on Form D since February 2024. Its chief executive is Nicolas Kirchuk.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 26, 2024Feb 12, 2024amended Apr 29, 2026$5,901,147of $7.9M target7$843KEquityRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Biomakers's Form D filed Apr 29, 2026.

Ruben Salanova
Ruben Salanova
Co-Founder & CMO, director
On every Form D that Biomakers has filed: 3 filings, from Feb 12, 2024 to Apr 29, 2026.
PF
Pablo Fernandez
Director
On every Form D that Biomakers has filed: 3 filings, from Feb 12, 2024 to Apr 29, 2026.
JM
Juan Marrone
Secretary
On every Form D that Biomakers has filed: 3 filings, from Feb 12, 2024 to Apr 29, 2026.
CV
Consuelo Valverde
Director
On every Form D that Biomakers has filed: 3 filings, from Feb 12, 2024 to Apr 29, 2026.
CL
Clarisa Lifsic
Director, Treasurer
On every Form D that Biomakers has filed: 3 filings, from Feb 12, 2024 to Apr 29, 2026.
Nicolas Kirchuk
Nicolas Kirchuk
Co-Founder & CEO, director
On every Form D that Biomakers has filed: 3 filings, from Feb 12, 2024 to Apr 29, 2026.

Sources

  1. SECBiomakers, Inc. Form D/A, filed Feb 11, 2025
  2. SECBiomakers, Inc. Form D, filed Feb 12, 2024
  3. SECBiomakers, Inc. filing history
  4. CompanyAbout Biomakers